About MCVI | Foundation | Physicians | Locations | Specialty Services | Testing | Electrophysiology Research | Events | Job Opportunities | Patient Links | Referring Physicians | Articles

PRECEDE HF

Principal Investigator:
Peter Fattal, MD      (MCVI)

Sub-Investigators:                 
Asim Yunus, MD

Sponsor:                                                    
Medtronic

Study Purpose:
PRECEDE-HF: Prospective, Randomized Evaluation of Cardiac Compass® with OptiVol® in the Early Detection of Decompensation Events for Heart Failure

Objective:
To collect data to compare subjects whose heart failure is managed using Cardiac Compass with OptiVol combined with standard treatment methods (called the Access Group) to subjects whose heart failure is managed by standard treatment methods only (called the Control Group).  This comparison will evaluate whether the additional monitoring provided by Cardiac Compass keeps subjects out of the hospital longer or delays the time to death.

Status:
Active enrollment
 

If you have any questions, please feel free to contact the coordinators, and they will be happy to answer any questions you have regarding this study.